NUS

Nu Skin Enterprises, Inc. Consumer Defensive - Household & Personal Products Investor Relations →

YES
69.0% BELOW
↓ Approaching Was -66.6% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $16.22
14-Week RSI 23 📉
Rel. Volume (14w) This week's trading vs. the 14-week average 2.3x — Surging
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.61 — Sellers winning

Nu Skin Enterprises, Inc. (NUS) closed at $5.02 as of 2026-06-19, trading 69.0% below its 200-week moving average of $16.22. This places NUS in the extreme value zone. The stock is currently moving closer to the line, down from -66.6% last week. With a 14-week RSI of 23, NUS is in oversold territory.

A big spike in selling this week — 2.3x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.

Over the past 1495 weeks of data, NUS has crossed below its 200-week moving average 27 times. On average, these episodes lasted 30 weeks. Historically, investors who bought NUS at the start of these episodes saw an average one-year return of +5.4%.

With a market cap of $244 million, NUS is a small-cap stock. The company generates a free cash flow yield of 25.3%, which is notably high. Return on equity stands at 7.0%. The stock trades at 0.3x book value.

Management has been repurchasing shares, with a 2.6% reduction over three years. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.

Over the past 28.8 years, a hypothetical investment of $100 in NUS would have grown to $53, compared to $1331 for the S&P 500. NUS has returned -2.2% annualized vs 9.4% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: NUS vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After NUS Crosses Below the Line?

Across 27 historical episodes, buying NUS when it crossed below its 200-week moving average produced an average return of +1.1% after 12 months (median -6.0%), compared to +9.8% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was +4.3% vs +18.1% for the index.

Each line shows $100 invested at the moment NUS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices NUS would reach each dislocation threshold.

Current Bean Score +1.65σ
Current FCF Yield 15.95%
Baseline Yield 11.67%
Historical σ 1.83pp

Dislocation Price Levels

Prices where NUS's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-06.

LevelσPriceSignal
Deep Value+2σ$5.16Unusually cheap — potential buy zone
Value+1σ$5.81Cheap vs. own history
Fair Value+0σ$6.63Historical mean behavior
Expensive-1σ$7.73Expensive vs. own history
Deep Expensive-2σ$9.26Unusually expensive — potential trim zone

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from NUS's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

2 stacked signals: buyback, value_vs_history · earnings quality deteriorating
Yield Dislocation +0.21σ Dividend yield vs own 10-yr norm
Drawdown Score +1.45σ Distance from line vs own history
Sector-Relative N/A Vs sector median this week
Buyback Acceleration -2.3pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 62th TTM buys / market cap, percentile of buyers
FCF Yield vs History +15.1pp Vs own recent annual mean
Earnings Quality Deteriorating Accrual gap trend (+11.9pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

NUS has crossed below its 200-week MA 27 times with an average 1-year return of +5.4% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Oct 1997Mar 19982135.1%-2.0%-46.8%
Jun 1998Nov 19982353.2%-8.0%-50.8%
Dec 1998Dec 199813.6%-60.3%-54.4%
Feb 1999Apr 200216573.5%-55.9%-55.0%
Jul 2002Aug 2002219.9%+27.2%+12.9%
Mar 2003Mar 200311.8%+140.9%+4.9%
Apr 2003Apr 200310.6%+189.2%+6.5%
Apr 2006Sep 20062020.1%+2.5%-47.2%
Sep 2006Oct 200621.8%-0.2%-48.7%
Jan 2007Mar 20086025.1%-14.0%-51.2%
Mar 2008Mar 200811.2%-40.1%-52.8%
Apr 2008Jun 20096045.2%-25.0%-52.6%
Jul 2009Jul 200910.1%+84.9%-45.9%
Aug 2014Mar 20153229.2%+1.4%-84.5%
May 2015Aug 20166548.8%-22.9%-85.9%
Oct 2016May 20172613.6%+15.6%-87.2%
May 2017May 201710.3%+49.4%-87.6%
Mar 2019Sep 20208063.9%-58.2%-86.8%
Oct 2020Nov 202045.1%-16.3%-87.6%
Dec 2020Dec 202010.2%-7.0%-88.2%
Feb 2021Mar 202136.5%+5.5%-87.5%
Apr 2021Apr 202110.2%-1.2%-88.3%
Aug 2021Dec 20211920.6%-8.8%-88.4%
Feb 2022Mar 202254.8%-10.8%-87.6%
Apr 2022Aug 20221610.2%-5.3%-87.1%
Aug 2022Jan 20232224.3%-41.5%-86.3%
Feb 2023Ongoing174+81.0%Ongoing-86.1%
Average30+5.4%

Frequently Asked Questions

Is NUS below its 200-week moving average?

Yes. As of 2026-06-19, Nu Skin Enterprises, Inc. (NUS) is trading 69.0% below its 200-week moving average of $16.22. The current price is $5.02.

What is NUS's 200-week moving average price?

Nu Skin Enterprises, Inc.'s 200-week moving average is $16.22 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when NUS drops below its 200-week moving average?

NUS has crossed below its 200-week moving average 27 times in our data. On average, buying at that moment produced a one-year return of +5.4%. These dips have historically been decent entry points. These episodes lasted 30 weeks on average.

Is NUS a good value right now?

Here's what our data says about NUS as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 23 (oversold). Free cash flow yield is 25.3%. Return on equity is 7.0%. Price-to-book is 0.3x. This is not a buy or sell recommendation — always do your own research.

How does NUS compare to the S&P 500?

Over the past 28.8 years, $100 invested in NUS would have grown to $53, compared to $1331 for the S&P 500. That's -2.2% annualized vs 9.4% for the index. NUS has underperformed the broader market over this period.

Does NUS pay a dividend?

Yes. Nu Skin Enterprises, Inc. currently pays a dividend yield of 475.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19